Acesso livre
Acesso livre

Covid-19 (Temas de Saúde Pública)

Editorial | Ética clínica: consentimento para vacinação de crianças.

4 Out, 2021 | 10:32h

Clinical ethics: consent for vaccination in children – Archives of Disease in Childhood

Nova análise mostra que os benefícios de se aplicar 2 doses de vacina contra COVID-19 em crianças de 12 a 17 anos supera os riscos.

4 Out, 2021 | 10:30h

Comunicado de imprensa: New analysis shows benefits of offering two doses of COVID-19 vaccine to children aged 12-17 clearly outweigh risks – The Royal Society of Medicine

Relatório original: Vaccinating adolescents against SARS-CoV-2 in England: a risk-benefit analysis

Contéudo relacionado: Covid: Single jab recommended for 12 to 15-year-olds by UK’s top doctors.

Editorial | Vacinação contra Covid-19: evidência de queda na imunidade é exagerada.

4 Out, 2021 | 10:29h

Covid-19 vaccination: evidence of waning immunity is overstated – The BMJ

Conteúdos relacionados:

COVID vaccine immunity is waning — how much does that matter? – “As debates about booster shots heat up, what’s known about the duration of vaccine-based immunity is still evolving”.

COVID vaccine effects wane over time but still prevent death and severe illness.

Perspective | What we actually know about waning immunity.

Another study shows Pfizer mRNA vaccine immunity is reduced over time.

[Press release – not published yet] Study shows vaccine protection wanes over time, but vaccines still offer good protection against severe disease.

Studies: COVID vaccine protection waning against infection but not hospitalization.

Pfizer says it’s time for a Covid booster; FDA and CDC say not so fast.

Testagem eficiente e direcionada de COVID-19 nas fronteiras via inteligência artificial.

1 Out, 2021 | 22:01h

Efficient and targeted COVID-19 border testing via reinforcement learning – Nature

Editorial: Greece used AI to curb COVID: what other nations can learn – Nature

Comentário: An algorithm may have helped slow the spread of COVID-19 in Greece – University of Southern California

 

Comentário no Twitter

 

Compreendendo a transição da COVID-19 para endemicidade.

1 Out, 2021 | 21:59h

Transition to endemicity: Understanding COVID-19 – Cell

Conteúdos relacionados:

COVID will likely shift from pandemic to endemic — but what does that mean?

Perspective | How Endemic COVID Becomes a Manageable Risk – “Businesses and schools must adapt, because the dual threat from the coronavirus and the flu will be too severe”.

Estudo randomizado com mais de 30.000 pacientes mostrou que a vacina da AstraZeneca é segura e teve 74% de eficácia contra infecção sintomática por SARS-CoV-2.

1 Out, 2021 | 20:27h

Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine – New England Journal of Medicine

 

Comentários no Twitter

 

[Comunicado de imprensa – Ainda não publicado] Candidata da Clover a vacina contra COVID-19 demonstra 79% de eficácia contra a variante Delta.

1 Out, 2021 | 20:25h

Clover’s COVID-19 Vaccine Candidate Demonstrates 79% Efficacy Against Delta in Global Phase 2/3 SPECTRA Trial Dominated by Variants of Concern and Interest – Clover Biopharmaceutical

Comentário: New Chinese vaccine could bolster global arsenal – Science

Recapitulando a pandemia: lições que aprendemos.

1 Out, 2021 | 20:24h

A pandemic recap: lessons we have learned – World Journal of Emergency Surgery

Mais de um 1/3 dos pacientes com COVID-19 são posteriormente diagnosticados com pelo menos um sintoma de “long COVID”.

1 Out, 2021 | 20:22h

Comunicado de imprensa: Over a third of COVID-19 patients diagnosed with at least one long-COVID symptom – University of Oxford

Estudo original: Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19 – PLOS Medicine

Comentários:

Two studies tie long COVID-19 to severe initial illness – CIDRAP

Covid: 37% of people have symptoms six months after infection – The Guardian

Long Covid is a bigger problem than we thought – CNN

Expert reaction to study looking at incidence and co-occurrence of long COVID symptoms following COVID-19 infection and also after influenza – Science Media Centre

Revisão sistemática | Caracterização da “long COVID”.

1 Out, 2021 | 19:37h

Characterising long COVID: a living systematic review – BMJ Global Health

Conteúdos relacionados:

Long Covid – The illness narratives.

New guidelines to help doctors manage long COVID patients published.

M-A: More than 50 long-term effects of COVID-19. (vários artigos sobre o tema)

 

Comentário no Twitter

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.